Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

BACKGROUND: On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at least 5 months earlier. Data are needed regarding t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Freedman, Laurence, Kalkstein, Nir, Mizrahi, Barak, Alroy-Preis, Sharon, Ash, Nachman, Milo, Ron, Huppert, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461568/
https://www.ncbi.nlm.nih.gov/pubmed/34525275
http://dx.doi.org/10.1056/NEJMoa2114255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461568/
https://www.ncbi.nlm.nih.gov/pubmed/34525275
http://dx.doi.org/10.1056/NEJMoa2114255

Ejemplares similares